ASTCT Presents Distinguished Honors at the 2022 Tandem Meetings
American Society for Transplantation and Cellular Therapy (ASTCT) presented top awards to leaders in the field of transplantation and cellular therapy at the Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR®
SALT LAKE CITY, April 27, 2022 (Newswire.com) - American Society for Transplantation and Cellular Therapy (ASTCT) presented top awards to leaders in the field of transplantation and cellular therapy at the Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR®.
Effie Petersdorf, M.D., was honored with the 2022 ASTCT Lifetime Achievement Award. Dr. Petersdorf is Professor, Clinical Research Division at the Fred Hutchinson Cancer Center, and Professor of Medicine, Medical Oncology Division, University of Washington School of Medicine. Dr. Petersdorf has devoted her research to the immunogenetics of the HLA system in transplantation.
The 2022 ASTCT Public Service Award was presented to Damiano Rondelli, M.D. Dr. Rondelli is the Michael Reese Professor of Hematology, Chief of the Division of Hematology/Oncology, and Director of BMT at the University of Illinois at Chicago. Dr. Rondelli leads a global initiative dedicated to improving access and resources for transplant and cellular therapy centers, particularly in those countries with constrained resources. Notably, Dr. Rondelli's initiative has assisted hospitals in Cuba, Nepal and Ukraine.
The ASTCT Board of Directors recognized James W. Young, M.D., with the 2022 ASTCT Special Recognition for his outstanding contributions to the New Investigator Awards program. Dr. Young has led the New Investigator Awards application, review and selection process for the last decade. During that time, more than 50 individuals were recipients of funding through the program.
###
About American Society for Transplantation and Cellular Therapy (ASTCT)
ASTCT is an international professional membership association of more than 3,000 physicians, investigators, and other health care professionals from more than 45 countries. Our mission is dedicated to improving the application and success of blood and marrow transplantation and related cellular therapies. We strive to be the leading organization promoting research, education, and clinical practice in the field. For more information about ASTCT, visit www.astct.org and follow ASTCT on Twitter @ASTCT.
Contact Jennifer Kasowicz, Director of Marketing, [email protected], 312-673-4970
Source: American Society for Transplantation and Cellular Therapy
Share:
Tags: ASTCT, blood cancer, bone marrow transplant